Innate Pharma S.A. EV 2011-2026 | IPHA

EV Jährlich Innate Pharma S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	259 M	288 M	412 M	132 M	69.7 M	195 M	234 M	16.1 M	15.6 M	24.9 M	33.5 M

Alle Zahlen in EUR-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
412 M	15.6 M	153 M

EV anderer Aktien in der Pharmaeinzelhändler

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Axsome Therapeutics AXSM	8.95 B	$ 164.05	-	$ 8.16 B	USA
Graybug Vision GRAY	8.71 M	-	-11.23 %	$ 9.65 M	USA
Apellis Pharmaceuticals APLS	3.01 B	$ 20.16	-	$ 2.54 B	USA
Aptorum Group Limited APM	9.45 M	$ 0.79	-	$ 4.31 M	China
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
BioMarin Pharmaceutical BMRN	11.9 B	$ 58.53	-	$ 11.2 B	USA
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA
AbCellera Biologics ABCL	1.22 B	$ 3.71	-	$ 1.11 B	Canada
Athersys ATHX	-37.4 M	-	3.77 %	$ 22.4 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
AVEO Pharmaceuticals AVEO	86.9 M	-	-	$ 521 M	USA
Brainstorm Cell Therapeutics BCLI	15.7 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
Burford Capital Limited BUR	3.22 B	$ 8.55	-	$ 1.38 B	Britain
Capricor Therapeutics CAPR	177 M	$ 25.84	-	$ 692 M	USA
BridgeBio Pharma BBIO	15.5 B	$ 64.53	-	$ 12.4 B	USA
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
CymaBay Therapeutics CBAY	3.36 B	-	-	$ 3.45 B	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Avid Bioservices CDMO	661 M	-	-	$ 789 M	USA
Codexis CDXS	354 M	$ 0.98	-3.92 %	$ 71.9 M	USA
Certara CERT	1.38 B	$ 7.24	-	$ 1.16 B	USA
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Checkpoint Therapeutics CKPT	174 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	-6.94 M	-	-16.75 %	$ 25.8 M	USA
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
Clovis Oncology CLVS	839 M	-	-7.23 %	$ 13 M	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Checkmate Pharmaceuticals CMPI	11.4 M	-	-	$ 231 M	USA
Coherus BioSciences CHRS	929 M	$ 1.65	-	$ 155 M	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
CTI BioPharma Corp. CTIC	664 M	-	-	$ 1.2 B	USA
CohBar CWBR	410 K	-	-15.44 %	$ 2.2 M	USA
Cyclacel Pharmaceuticals CYCC	8.71 M	-	-5.98 %	$ 34.1 M	USA
Cyclacel Pharmaceuticals CYCCP	112 M	-	-4.36 %	$ 27 M	USA
Cabaletta Bio CABA	-155 M	$ 3.25	-	$ 3.8 M	USA
Deciphera Pharmaceuticals DCPH	1.24 B	-	-	$ 2.18 B	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
Corvus Pharmaceuticals CRVS	88.4 M	$ 17.53	-	$ 842 M	USA
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Entasis Therapeutics Holdings ETTX	51.1 M	-	-	$ 105 M	USA
Evofem Biosciences EVFM	75.8 M	-	7.55 %	$ 38.1 M	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA